5 Years Development

Income Statement (MEUR)

  IFRS 2020
Continuing operations		 IFRS 2019
Continuing operations		 IFRS 2018
Continuing
operations		 IFRS 2017
Continuing
operations		 IFRS 2016
Continuing
operations
Net sales, (MEUR) *) 78.4 75.2 62.8 51.6 64.2
     Net sales change, % 4.2 19.7 21.7 -19.6 13.0
Operating profit/loss, (MEUR) *) 2.1 6.3 2.8 -6.2 2.5
     % of net sales 2.7 8.4 4.5 -12.0 4.0
Profit / loss for Continuing Operations before taxes, (MEUR) 1.6 5.9 2.7 -5.8 3.1
     % of net sales 2.1 7.9 4.3 -11.3 4.9
Profit of the year from Continuing Operations, (MEUR) 2.2 7.6 4.0 -4.8 3.5
     % of net sales 2.8 10.2 6.4 -9.2 5.5
Profit after tax for the year from Discontinued Operations, (MEUR) 0 0 0 1.7 0.0
     % of net sales 0 0.0 0.0 3.2 0.0
Profit for the year attributable to equity holders of the parent, (MEUR) 2,2 7.6 4.0 -3.1 3.5
     % of net sales 2,8 10.2 6.4 -6.0 5.5

Balance sheet (MEUR)

  IFRS 2020
Continuing operations		 IFRS 2019
Continuing operations		 IFRS 2018
Continuing operations		 IFRS 2017
Continuing
operations		 IFRS 2016
Continuing
operations
Non-current assets 86.4 80.5 65.9 46.7 30.3
Inventories 20.9 18.2 14.6 10.6 4.1
Current assets 50.7  55.6 51.9 81.1 118.9
Assets classified as held for sale          
Sharelolders' equity 114.2 112.3 110.0 116.7 130.6
Non-current liabilities 21.9 22.1 1.9 1.5 3.1
Current liabilities 21.8 19.9 20.5 20.2 19.6
Liabilities classified as held for sale          
Balance sheet total 158.0 154.2 132.4 138.4 153.3

Profitability and Other Key Figures

  IFRS 2020
Continuing operations		 IFRS 2019
Continuing operations		 IFRS 2018
Continuing operations		 IFRS 2017
Continuing
operations		 IFRS 2016
Continuing
operations
Return on equity, % (ROE) 1.9  6.9 3.6 -3.9 2.6
Return on investment % (ROI) 1.6  5.0 3.7 -4.5 2.6
Interest-bearing net liabilities, (MEUR) -2.1 -12.6 -29.4 -61.7 -91.8
Net gearing, % -1.9 -11.2 -26.7 -52.9 -70.3
Equity ratio, % 73.1 73.4 84.7 85.6 87.0
Gross investments, (MEUR) *) 17.4 21.3 21.2 20.1 18.5
     Gross investments, % of net sales 22.2 28.3 33.8 38.8 28.8
R&D costs, (MEUR) *) 22.8 25.1 21.6 15.0 6.9
     R&D costs, % of net sales 29.1 33.4 34.4 29.1 10.8
Average personnel during the period, parent and subsidiaries *) 673 665 660 614 569

Stock-Related Financial Ratios

  IFRS 2020 IFRS 2019 IFRS 2018 IFRS 2017 IFRS 2016

Earnings per share from continuing operations, EUR		          
     Basic earnings per share 0.061 0.214 0.113 -0.133 0.098
     Diluted earnings per share 0.061 0.214 0.113 -0.133 0.098

Earnings per share from discontinued operations, EUR		          
     Basic earnings per share       0.046 0.000
     Diluted earnings per share       0.046 0.000

Earnings per share from continuing and discontinued operations, EUR		          
     Basic earnings per share 0.061 0.214 0.113 -0.087 0.098
     Diluted earnings per share 0.061 0.214 0.113 -0.087 0.098
Equity per share, EUR 3.2 3.15 3.08 3.27 3.66
Dividend per share, EUR *) 0.0 0.1 0.15 0.3 0.3
Dividend per earnings, % 0.0 46.7 132.7 -344.6 305.3
P/E ratio 94.9 30.4 53.0 -64.9 57.7
Effective dividend yield, % 0.0 1.5 2.0 5.3 5.3

Market values of shares (EUR)		          
     Highest 7.67 8.03 8.1 7.88 7.40
     Lowest 3.40 5.91 4.71 5.55 5.15
     Average 5.74 6.70 5.98 6.55 6.05
     At the end of period 5.79 6.50 7.61 5.65 5.67
Market value of the stock, (MEUR) 206.7 232.0 271.6 201.7 202.4

Trading value of shares		          
     MEUR 117.9 51.5 75.4 83.1 126.4
     1000 pcs 20 557 7 689 12 608 12 684 20 888
     Related to average number of shares % 57.6 21.5 35.3 35.5 58.6
Adjusted number of the shares at the end of the period (1000 pcs) 35 693 35 693 35 693 35 693 35 693
Adjusted number of the shares average during the period (1000 pcs) 35 693 35 693 35 693 35 693 35 670
Adjusted number of the shares average for the period diluted with stock options (1000 pcs) 35 693 35 693 35 693 35 693 35 670


*) Proposal of the BoD for 2021